Want to join the conversation?
$ZBH recently announced the strategic acquisition of Clinical Graphics, B.V., a novel imaging company specializing in 3D range-of-motion simulation technology to inform treatment decisions for common hip conditions requiring early intervention. The company plans to integrate the new imaging platform to enhance its hip preservation portfolio.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?